A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Public ClinicalTrials.gov record NCT07201129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of Cenerimod in Adult Patients With Systemic Lupus Erythematosus and Active Lupus Nephritis in Combination With Background Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic lupus erythematosus and active lupus nephritis. It will also learn about the safety of cenerimod. The main questions it aims to answer are: * Does cenerimod improve kidney function in participants? * What medical problems do participants have when taking cenerimod? Researchers will compare cenerimod to a placebo (a look-alike substance that contains no drug) to see how well cenerimod works when it is added to regular treatment. Participants will: * Take cenerimod or a placebo every day for 76 weeks (approximately 1.5 years), on top of regular treatment. * Visit the clinic every 1 to 3 months for checkups and tests.
Study identification
- NCT ID
- NCT07201129
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 8, 2026
- Primary completion
- Jul 31, 2029
- Completion
- Jan 31, 2030
- Last update posted
- Jul 29, 2026
2026 – 2030
United States locations
- U.S. sites
- 14
- U.S. states
- 3
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dolphin Medical Research | Doral | Florida | 33172 | Recruiting |
| Alloy Clinical Research LLC | Kissimmee | Florida | 34741 | Recruiting |
| SouthCoast Research Center | Miami | Florida | 33136 | Recruiting |
| Allied Biomedical Research Institute | Miami | Florida | 33155 | Recruiting |
| DH NationalResearchCenters INC | Miami | Florida | 33155 | Recruiting |
| ProfessionalResearchCenter INC | Miami | Florida | 33172 | Recruiting |
| San Marcus Research Clinic, Inc. | Miami Lakes | Florida | 33014 | Recruiting |
| Revive Research Institute, LLC | Sterling Heights | Michigan | 48313 | Recruiting |
| Rheumatology Care Center, PLLC | Bellaire | Texas | 77401 | Recruiting |
| Texas Arthritis Center | El Paso | Texas | 79902 | Recruiting |
| Novel Research, LLC. | Houston | Texas | 77024 | Recruiting |
| Northwest Houston Arthritis | Houston | Texas | 77090 | Recruiting |
| Discovery Clinical Trials LLC | San Antonio | Texas | 78229 | Recruiting |
| Azul Bioresearch Llc | Sugarland | Texas | 77479 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07201129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07201129 live on ClinicalTrials.gov.